Generic Industry Likely To See Increasing Geographic Diversification - Barr
This article was originally published in PharmAsia News
Executive Summary
The generic drug industry has myriad reasons to expand into non-U.S. markets and will continue to do so, according to Barr CEO Bruce Downey